 |
Benefits: /
Your filings are automatically published to your site as they are filed.Investors don't have to leave your site to see filings.
Product Description
Once a report has been filed with the SEC it will be available on the website.
|
SEC Filings
|
Section 16 Filings Only
|
| |
| Item 9.01 |
|
Financial Statements and Exhibits. |
| |
|
|
|
|
| |
|
(d) |
|
Exhibits |
| |
|
|
|
|
| |
|
Exhibit No. |
|
Description |
| |
|
|
|
|
| |
|
99.1 |
|
Press Release of NovaDel Pharma Inc. dated August 22, 2011, titled “NovaDel Signs Exclusive License and Distribution Agreement with Rechon Life Science AB to Manufacture and Commercialize Zolpimist® outside of the US and Canada” (incorporated herein by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 22, 2011). |
|
|
|
|
|
|
You are viewing our Quote and Chart Demo using ticker symbol NVDL
|
|
F 888.329.6696